Weitz & Luxenberg partner Ellen Relkin remains as busy as ever this November, with two more speaking engagements lined up. The first is George Washington University Law School’s conference titled Bench, Bar & Bankruptcy: Complex Litigation Forum 2022. It is scheduled for November 17-18 in Washington, DC. The second is HarrisMartin’s MDL Conference: Navigating Current…

Weitz & Luxenberg’s request for consolidation of cases filed in numerous federal courts into a multidistrict litigation (MDL) and to transfer actions against Exactech to the Eastern District of New York in Brooklyn was approved on October 7 by the U.S. Judicial Panel on Multidistrict Litigation. The MDL is No. 3044 – In re: Exactech…

Philips Respironics is recalling more ventilators due to continuing issues with its polyurethane (PE-PUR) sound abatement foam, according to the U.S. Food and Drug Administration (FDA). The FDA announced the expanded recall on January 26, identifying it as a Class I recall. This is “the most serious type of recall. Use of these devices may…

Weitz & Luxenberg is representing clients needing a revision surgery due to failure from an Exactech knee implant. Potential clients may be suffering from osteolysis (bone loss), loosening, lysis, swelling, difficulty walking, and pain associated with polyethylene wear. The defective devices, containing Exactech Knee and Ankle Ultra-High Molecular Weight Polyethylene, were recalled by the manufacturer….

Attorney Danielle Gold has been appointed to serve on the Plaintiffs’ Executive Committee in the Elmiron multidistrict litigation (MDL). The litigation alleges that taking pentosan polysulfate sodium (PPS) to reduce bladder pain and discomfort of interstitial cystitis has resulted in serious eye damage. Gold has been appointed along with a select and diverse group of…

Weitz & Luxenberg is pursuing legal cases on behalf of people taking Oxbryta (voxelotor) to treat sickle cell anemia. Potential clients may be people suffering from an increase in vaso-occlusion crisis events or the death of a loved one. These are the main Oxbryta side effects leading to its recall. If you used Oxbryta and…

Weitz & Luxenberg is investigating cases of severe liver damage in women who took Veozah to treat menopausal hot flashes. The U.S. Food and Drug Administration (FDA) warns that using Veozah (fezolinetant), “can cause rare but serious liver injury.” If you used Veozah to treat menopausal hot flashes and developed a severe liver injury, reach…

This fall, Weitz & Luxenberg attorneys are busier than ever. Several of our skilled attorneys are presenting at these fall conferences: Perrin Conferences National Asbestos Litigation Conference 2023, Shades of Mass 2023, 2023 New Jersey Asbestos Litigation Conference, Mass Torts Made Perfect 2023, and NJAJ Meadowlands Seminar 2023: Mass Tort. W&L is proud of our…

Weitz & Luxenberg is taking cases of severe hearing damage in adults who took Tepezza to treat thyroid eye disease (TED). People across the country have filed lawsuits against Horizon Pharmaceuticals, Inc., for their pain and suffering. The suits state the patients were not sufficiently warned that Tepezza could cause severe, permanent, hearing damage including…

Weitz & Luxenberg attorneys Ellen Relkin and Danielle Gold continue to lead efforts against Exactech due to recalled hip and knee implant failures. The ongoing multidistrict Litigation (MDL) is set in the United States District Court for the Eastern District of New York. Since being appointed to leadership positions in December 2022, the W&L team…